TY  - JOUR 
AU  - Liu, P.
AU  - Wang, Z.
AU  - Brown, S.
AU  - Kannappan, V.
AU  - Tawari, P. E.
AU  - Jiang, W.
AU  - Irache, J. M.
AU  - Tang, J. Z.
AU  - Armesilla, Angel L.
AU  - Darling, J. L.
AU  - Tang, X.
AU  - Wang, Weiguang
PY  - 2014
SN  - 1949-2553
UR  - http://hdl.handle.net/20.500.12020/1598
AB  - Breast cancer stem cells (BCSCs) are pan-resistant to different anticancer agents and responsible for cancer relapse. Disulfiram (DS), an antialcoholism drug, targets CSCs and reverses pan-chemoresistance. The anticancer application of DS is limited...
LA  - en
PB  - Impact journals LLC
TI  - Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
DO  - https://doi.org/10.18632/oncotarget.2166
T2  - Oncotarget
M2  - 7471
KW  - Disulfiram
KW  - NFkB
KW  - Breast Cancer
KW  - Cancer Stem Cells
KW  - Chemoresistance
VL  - 5
ER  -